PPARα-mediated responses in human adult liver stem cells: In vivo/in vitro and cross-species comparisons

Journal of Steroid Biochemistry and Molecular Biology

Volumn 138, Issue , 2013, Pages 236-247

  Kim, S ^a,b   Kiyosawa, N ^d   Burgoon, L D ^b   Chang, C C ^c   Zacharewski, T R ^a,b  

^a Michigan State University   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d DAIICHI SANKYO CO   (Japan)

Author keywords

Clofibrate; Comparative; Human liver stem cell; Liver; PPAR alpha; Toxicogenomics; WY 14,643

Indexed keywords

ADFP PROTEIN; ANGPTL4 PROTEIN; BMF PROTEIN; CLOFIBRATE; DIMETHYL SULFOXIDE; LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PIRINIXIC ACID; PYRUVATE DEHYDROGENASE KINASE 4; SESAME SEED OIL; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CELL CYCLE; CELL STRAIN HEPG2; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; HEPATOMA CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; LIPID METABOLISM; LIPID TRANSPORT; LIVER CELL; LIVER STEM CELL; LIVER WEIGHT; MEDIATOR; MOUSE; NONHUMAN; PROTEIN FOLDING; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECIES COMPARISON; STEM CELL; TUMOR SUPPRESSOR GENE; WEIGHT GAIN;

CLOFIBRATE; COMPARATIVE; HUMAN LIVER STEM CELL; LIVER; PPAR ALPHA; TOXICOGENOMICS; WY-14,643;

ANIMALS; CLOFIBRATE; DIMETHYL SULFOXIDE; GENE EXPRESSION; HEP G2 CELLS; HUMANS; LIVER; MICE; PPAR ALPHA; PYRIMIDINES; STEM CELLS;

EID: 84884510945     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2013.06.004     Document Type: Article

References (75)

1. B. Desvergne, and W. Wahli Peroxisome proliferator-activated receptors: nuclear control of metabolism Endocrine Reviews 20 1999 649 688 (Pubitemid 30650602)
2. S.R. Pyper, N. Viswakarma, S. Yu, and J.K. Reddy PPARalpha: energy combustion, hypolipidemia, inflammation and cancer Nuclear Receptor Signaling 8 2010 e002
3. W. Ahmed, O. Ziouzenkova, J. Brown, P. Devchand, and S. Francis PPARs and their metabolic modulation: new mechanisms for transcriptional regulation? Journal of Internal Medicine 262 2007 184 198 (Pubitemid 47087629)
4. M.A. Peraza, A.D. Burdick, H.E. Marin, F.J. Gonzalez, and J.M. Peters The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR) Toxicological Sciences 90 2006 269 295
5. J.P. Berger, T.E. Akiyama, and P.T. Meinke PPARs: therapeutic targets for metabolic disease Trends in Pharmacological Sciences 26 2005 244 251 (Pubitemid 40603072)
6. F. Lalloyer, and B. Staels Fibrates, glitazones, and peroxisome proliferator-activated receptors Arteriosclerosis, Thrombosis, and Vascular Biology 30 2010 894 899
7. D. Auboeuf, J. Rieusset, L. Fajas, P. Vallier, and V. Frering Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients Diabetes 46 1997 1319 1327 (Pubitemid 27315281)
8. J.M. Thorp, and W.S. Waring Modification of metabolism and distribution of lipids by ethyl chlorophenoxyisobutyrate Nature 194 1962 948 949
9. J.K. Reddy, D.L. Azarnoff, and C.E. Hignite Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens Nature 283 1980 397 398 (Pubitemid 10125816)
10. C.A. Jackevicius, J.V. Tu, J.S. Ross, D.T. Ko, and D. Carreon Use of fibrates in the United States and Canada JAMA 305 2011 1217 1224
11. S.S. Lee, T. Pineau, J. Drago, E.J. Lee, and J.W. Owens Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators Molecular and Cellular Biology 15 1995 3012 3022
12. J.M. Peters, R.C. Cattley, and F.J. Gonzalez Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643 Carcinogenesis 18 1997 2029 2033 (Pubitemid 28134725)
13. IARC Peroxisome Proliferation and Its Role in Carcinogenesis, IARC Technical Report 1995
14. J. Ashby, A. Brady, C.R. Elcombe, B.M. Elliott, and J. Ishmael Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis Human and Experimental Toxicology 13 Suppl. 2 1994 S1 S117
15. R.C. Cattley, J. DeLuca, C. Elcombe, P. Fenner-Crisp, and B.G. Lake Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans? Regulatory Toxicology and Pharmacology 27 1998 47 60 (Pubitemid 28289021)
16. C. Cheung, T.E. Akiyama, J.M. Ward, C.J. Nicol, and L. Feigenbaum Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha Cancer Research 64 2004 3849 3854 (Pubitemid 38697295)
17. K. Morimura, C. Cheung, J.M. Ward, J.K. Reddy, and F.J. Gonzalez Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor alpha to Wy-14,643-induced liver tumorigenesis Carcinogenesis 27 2006 1074 1080
18. J.D. Tugwood, T.C. Aldridge, K.G. Lambe, N. Macdonald, and N.J. Woodyatt Peroxisome proliferator-activated receptors: structures and function Annals of the New York Academy of Sciences 804 1996 252 265 (Pubitemid 27056614)
19. C.N. Palmer, M.H. Hsu, K.J. Griffin, J.L. Raucy, and E.F. Johnson Peroxisome proliferator activated receptor-alpha expression in human liver Molecular Pharmacology 53 1998 14 22 (Pubitemid 28068368)
20. S. Yu, and J.K. Reddy Transcription coactivators for peroxisome proliferator-activated receptors Biochimica et Biophysica Acta 1771 2007 936 951 (Pubitemid 47198542)
21. M. Ammerschlaeger, J. Beigel, K.U. Klein, and S.O. Mueller Characterization of the species-specificity of peroxisome proliferators in rat and human hepatocytes Toxicological Sciences 78 2004 229 240 (Pubitemid 38559671)
22. M. Seimandi, G. Lemaire, A. Pillon, A. Perrin, and I. Carlavan Differential responses of PPARalpha, PPARdelta, and PPARgamma reporter cell lines to selective PPAR synthetic ligands Analytical Biochemistry 344 2005 8 15 (Pubitemid 41569372)
23. K. Yu, W. Bayona, C.B. Kallen, H.P. Harding, and C.P. Ravera Differential activation of peroxisome proliferator-activated receptors by eicosanoids Journal of Biological Chemistry 270 1995 23975 23983
24. S. Kim, E. Dere, L.D. Burgoon, C.C. Chang, and T.R. Zacharewski Comparative analysis of AhR-mediated TCDD-elicited gene expression in human liver adult stem cells Toxicological Sciences 112 2009 229 244
25. C.C. Chang, J.L. Tsai, K.K. Kuo, K.H. Wang, and C.H. Chiang Expression of Oct-4, alpha fetoprotein and vimentin and lack of gap-junctional intercellular communication (GJIC) as common phenotypes for human adult liver stem cells and hepatoma cells Proceedings of the American Association for Cancer Research 45 2004 642
26. L. Patrawala, T. Calhoun, R. Schneider-Broussard, J. Zhou, and K. Claypool Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic Cancer Research 65 2005 6207 6219 (Pubitemid 40994406)
27. J.E. Visvader, and G.J. Lindeman Cancer stem cells in solid tumours: accumulating evidence and unresolved questions Nature Reviews Cancer 8 2008 755 768
28. M.R. Alison, S. Islam, and S. Lim Stem cells in liver regeneration, fibrosis and cancer: the good, the bad and the ugly Journal of Pathology 217 2009 282 298
29. C. Crisafulli, S. Bruscoli, E. Esposito, E. Mazzon, and R. Di Paola PPAR-alpha contributes to the anti-inflammatory activity of 17beta-estradiol Journal of Pharmacology and Experimental Therapeutics 331 2009 796 807
30. D.R. Boverhof, L.D. Burgoon, C. Tashiro, B. Chittim, and J.R. Harkema Temporal and dose-dependent hepatic gene expression patterns in mice provide new insights into TCDD-mediated hepatotoxicity Toxicological Sciences 85 2005 1048 1063 (Pubitemid 40846879)
31. A.K. Kopec, D.R. Boverhof, L.D. Burgoon, D. Ibrahim-Aibo, and J.R. Harkema Comparative toxicogenomic examination of the hepatic effects of PCB126 and TCDD in immature, ovariectomized C57BL/6 mice Toxicological Sciences 102 2008 61 75 (Pubitemid 351250469)
32. A.K. Kopec, L.D. Burgoon, D. Ibrahim-Aibo, B.D. Mets, and C. Tashiro PCB153-elicited hepatic responses in the immature, ovariectomized C57BL/6 mice: comparative toxicogenomic effects of dioxin and non-dioxin-like ligands Toxicology and Applied Pharmacology 243 2010 359 371
33. A.K. Kopec, L.D. Burgoon, D. Ibrahim-Aibo, A.R. Burg, and A.W. Lee Automated dose-response analysis and comparative toxicogenomic evaluation of the hepatic effects elicited by TCDD, TCDF, and PCB126 in C57BL/6 mice Toxicological Sciences 118 2010 286 297
34. E. Yoshii Cytotoxic effects of acrylates and methacrylates: relationships of monomer structures and cytotoxicity Journal of Biomedical Materials Research 37 1997 517 524 (Pubitemid 27514859)
35. J.E. Eckel, C. Gennings, T.M. Therneau, L.D. Burgoon, and D.R. Boverhof Normalization of two-channel microarray experiments: a semiparametric approach Bioinformatics 21 2005 1078 1083 (Pubitemid 40467931)
36. J.E. Eckel, C. Gennings, V.M. Chinchilli, L.D. Burgoon, and T.R. Zacharewski Empirical Bayes gene screening tool for time-course or dose-response microarray data Journal of Biopharmaceutical Statistics 14 2004 647 670 (Pubitemid 39296091)
37. L.D. Burgoon, and T.R. Zacharewski dbZach toxicogenomic information management system Pharmacogenomics 8 2007 287 291 (Pubitemid 46477740)
38. A.I. Saeed, V. Sharov, J. White, J. Li, and W. Liang TM4: a free, open-source system for microarray data management and analysis Biotechniques 34 2003 374 378 (Pubitemid 36184095)
39. G. Dennis Jr., B.T. Sherman, D.A. Hosack, J. Yang, and W. Gao DAVID: Database for Annotation, Visualization, and Integrated Discovery Genome Biology 4 2003 P3
40. S. Rozen, and H. Skaletsky Primer3 on the WWW for general users and for biologist programmers Methods in Molecular Biology 132 2000 365 386
41. J. Vandesompele, K. De Preter, F. Pattyn, B. Poppe, and N. Van Roy Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes Genome Biology 3 2002 RESEARCH0034
42. T. Yuen, E. Wurmbach, R.L. Pfeffer, B.J. Ebersole, and S.C. Sealfon Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays Nucleic Acids Research 30 2002 e48
43. J.K. Reddy, M.S. Rao, D.L. Azarnoff, and S. Sell Mitogenic and carcinogenic effects of a hypolipidemic peroxisome proliferator, [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643), in rat and mouse liver Cancer Research 39 1979 152 161 (Pubitemid 9090427)
44. T. Suzuki, M. Jin, Y. Dewa, R. Ichimura, and Y. Shimada Evaluation of in vivo liver genotoxic potential of Wy-14,643 and piperonyl butoxide in rats subjected to two-week repeated oral administration Archives of Toxicology 84 2010 493 500
45. M.N. Cayen Disposition, metabolism and pharmacokinetics of antihyperlipidemic agents in laboratory animals and man Pharmacology and Therapeutics 29 1985 157 204 (Pubitemid 16168250)
46. NTP NTP Technical Report on the Toxicity Studies of Wy-14,643 (CAS No. 50892-23-4) Administered in Feed to Sprague-Dawley Rats, B6C3F1 Mice, and Syrian Hamsters, Toxicity Report Series No. 62 2007
47. T.M. Willson, P.J. Brown, D.D. Sternbach, and B.R. Henke The PPARs: from orphan receptors to drug discovery Journal of Medicinal Chemistry 43 2000 527 550 (Pubitemid 30127149)
48. J.E. Klaunig, M.A. Babich, K.P. Baetcke, J.C. Cook, and J.C. Corton PPARalpha agonist-induced rodent tumors: modes of action and human relevance Critical Reviews in Toxicology 33 2003 655 780 (Pubitemid 38037444)
49. C. Blanquart, O. Barbier, J.C. Fruchart, B. Staels, and C. Glineur Peroxisome proliferator-activated receptor alpha (PPARalpha) turnover by the ubiquitin-proteasome system controls the ligand-induced expression level of its target genes Journal of Biological Chemistry 277 2002 37254 37259
50. H. Ren, B. Vallanat, H.M. Brown-Borg, R. Currie, and J.C. Corton Regulation of proteome maintenance gene expression by activators of peroxisome proliferator-activated receptor alpha PPAR Research 2010 727194
51. S.P. Anderson, P. Howroyd, J. Liu, X. Qian, and R. Bahnemann The transcriptional response to a peroxisome proliferator-activated receptor alpha agonist includes increased expression of proteome maintenance genes Journal of Biological Chemistry 279 2004 52390 52398 (Pubitemid 39662730)
52. D.M. Zaiss, S. Standera, P.M. Kloetzel, and A.J. Sijts PI31 is a modulator of proteasome formation and antigen processing Proceedings of the National Academy of Sciences of the United States of America 99 2002 14344 14349 (Pubitemid 35257674)
53. B. Vallanat, S.P. Anderson, H.M. Brown-Borg, H. Ren, and S. Kersten Analysis of the heat shock response in mouse liver reveals transcriptional dependence on the nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha) BMC Genomics 11 2010 16
54. A. Qu, Y.M. Shah, T. Matsubara, Q. Yang, and F.J. Gonzalez PPARalpha-dependent activation of cell cycle control and DNA repair genes in hepatic nonparenchymal cells Toxicological Sciences 118 2010 404 410
55. N.F. Cariello, E.H. Romach, H.M. Colton, H. Ni, and L. Yoon Gene expression profiling of the PPAR-alpha agonist ciprofibrate in the cynomolgus monkey liver Toxicological Sciences 88 2005 250 264 (Pubitemid 41548767)
56. J.A. Kramer, E.A. Blomme, R.T. Bunch, J.C. Davila, and C.J. Jackson Transcription profiling distinguishes dose-dependent effects in the livers of rats treated with clofibrate Toxicologic Pathology 31 2003 417 431 (Pubitemid 36897238)
57. S. Ramanan, M. Kooshki, W. Zhao, F.C. Hsu, and M.E. Robbins PPARalpha ligands inhibit radiation-induced microglial inflammatory responses by negatively regulating NF-kappaB and AP-1 pathways Free Radical Biology and Medicine 45 2008 1695 1704
58. P. Delerive, K. De Bosscher, S. Besnard, W. Vanden Berghe, and J.M. Peters Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1 Journal of Biological Chemistry 274 1999 32048 32054
59. P. Delerive, P. Gervois, J.C. Fruchart, and B. Staels Induction of IkappaBalpha expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-alpha activators Journal of Biological Chemistry 275 2000 36703 36707 (Pubitemid 32002075)
60. R. Stienstra, S. Mandard, N.S. Tan, W. Wahli, and C. Trautwein The interleukin-1 receptor antagonist is a direct target gene of PPARalpha in liver Journal of Hepatology 46 2007 869 877 (Pubitemid 46529035)
61. P.R. Devchand, H. Keller, J.M. Peters, M. Vazquez, and F.J. Gonzalez The PPARalpha-leukotriene B4 pathway to inflammation control Nature 384 1996 39 43
62. E. Ip, G. Farrell, P. Hall, G. Robertson, and I. Leclercq Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice Hepatology 39 2004 1286 1296 (Pubitemid 38569050)
63. A. Madej, B. Okopien, J. Kowalski, M. Zielinski, and J. Wysocki Effects of fenofibrate on plasma cytokine concentrations in patients with atherosclerosis and hyperlipoproteinemia IIb International Journal of Clinical Pharmacology and Therapeutics 36 1998 345 349 (Pubitemid 28271555)
64. C. Fernandez-Miranda, M. Perez-Carreras, F. Colina, G. Lopez-Alonso, and C. Vargas A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease Digestive and Liver Disease 40 2008 200 205 (Pubitemid 351181792)
65. J.W. Lawrence, Y. Li, S. Chen, J.G. DeLuca, and J.P. Berger Differential gene regulation in human versus rodent hepatocytes by peroxisome proliferator-activated receptor (PPAR) alpha. PPAR alpha fails to induce peroxisome proliferation-associated genes in human cells independently of the level of receptor expression Journal of Biological Chemistry 276 2001 31521 31527
66. F.J. Gonzalez, and Y.M. Shah PPARalpha: mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators Toxicology 246 2008 2 8
67. J.E. Walgren, D.T. Kurtz, and J.M. McMillan Expression of PPAR(alpha) in human hepatocytes and activation by trichloroacetate and dichloroacetate Research Communications in Molecular Pathology and Pharmacology 108 2000 116 132 (Pubitemid 33104165)
68. P. Gervois, I.P. Torra, G. Chinetti, T. Grotzinger, and G. Dubois A truncated human peroxisome proliferator-activated receptor alpha splice variant with dominant negative activity Molecular Endocrinology 13 1999 1535 1549 (Pubitemid 30650594)
69. U. Varanasi, R. Chu, Q. Huang, R. Castellon, and A.V. Yeldandi Identification of a peroxisome proliferator-responsive element upstream of the human peroxisomal fatty acyl coenzyme A oxidase gene Journal of Biological Chemistry 271 1996 2147 2155 (Pubitemid 26047804)
70. Y. Jia, C. Qi, P. Kashireddi, S. Surapureddi, and Y.J. Zhu Transcription coactivator PBP, the peroxisome proliferator-activated receptor (PPAR)-binding protein, is required for PPARalpha-regulated gene expression in liver Journal of Biological Chemistry 279 2004 24427 24434 (Pubitemid 38725306)
71. K. Matsumoto, S. Yu, Y. Jia, M.R. Ahmed, and N. Viswakarma Critical role for transcription coactivator peroxisome proliferator-activated receptor (PPAR)-binding protein/TRAP220 in liver regeneration and PPARalpha ligand-induced liver tumor development Journal of Biological Chemistry 282 2007 17053 17060 (Pubitemid 47093249)
72. A. Guillouzo Liver cell models in in vitro toxicology Environmental Health Perspectives 106 Suppl. 2 1998 511 532 (Pubitemid 28256760)
73. T. Kubota, T. Yano, K. Fujisaki, Y. Itoh, and R. Oishi Fenofibrate induces apoptotic injury in cultured human hepatocytes by inhibiting phosphorylation of Akt Apoptosis 10 2005 349 358 (Pubitemid 40603488)
74. G. Martinasso, M. Oraldi, A. Trombetta, M. Maggiora, and O. Bertetto Involvement of PPARs in cell proliferation and apoptosis in human colon cancer specimens and in normal and cancer cell lines PPAR Research 2007 93416
75. H. Puthalakath, A. Villunger, L.A. O'Reilly, J.G. Beaumont, and L. Coultas Bmf: a proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis Science 293 2001 1829 1832 (Pubitemid 32845780)